Use of AI to develop health economic evidence for optimized patient access
For a thorough understanding of the AI journey in healthcare, and its potential to transform and improve evidence generation and market access, listen to Rito Bergemann, MD, PhD and Jacqueline Vanderpuye-Orgle, MSc, PhD in their HEOR Theater presentation at the ISPOR US event. AI and human intelligence will play an integral part in RWD analysis and HEOR evidence, and they discuss its growing importance for optimized patient access.
Related Insights
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Whitepaper
Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews
Mar 15, 2023
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Blog
Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data
Oct 15, 2021
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023
Whitepaper
Optimizing Biosensor-based Trials
Feb 1, 2023
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Whitepaper
Overview of China's Market Approval Policy Med Insurance Payment System
Apr 7, 2022
Related Insights
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Whitepaper
Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews
Mar 15, 2023
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Blog
Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data
Oct 15, 2021
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023
Whitepaper
Optimizing Biosensor-based Trials
Feb 1, 2023
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Whitepaper
Overview of China's Market Approval Policy Med Insurance Payment System
Apr 7, 2022